NEW YORK, May 7 - A Roche official said today that the Swiss pharma giant will introduce six new diagnostic products over the next 18 months based on the Affymetrix GeneChip platform it licensed in January.
...and receive Daily News bulletins.
Already have an account?Login Now.
The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.
Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.
CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.
In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.